Pages that link to "Q42732353"
Jump to navigation
Jump to search
The following pages link to Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. (Q42732353):
Displaying 33 items.
- Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy (Q27003171) (← links)
- Gut microbiota: its role in hepatic encephalopathy (Q28084576) (← links)
- Hepatic encephalopathy (Q30423851) (← links)
- Pathogenesis, diagnosis, and treatment of hepatic encephalopathy (Q30907818) (← links)
- Gut microbiota, inflammation and hepatic encephalopathy: a puzzle with a solution in sight (Q33360248) (← links)
- Oxidative stress as a crucial factor in liver diseases (Q33845484) (← links)
- Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study (Q34550014) (← links)
- Gut microbiota and hepatic encephalopathy (Q34609555) (← links)
- Neuropsychological functioning and health-related quality of life: pediatric acute liver failure study group results (Q34771736) (← links)
- Minimal hepatic encephalopathy impairs quality of life. (Q35642834) (← links)
- Contributions of microdialysis to new alternative therapeutics for hepatic encephalopathy (Q37139141) (← links)
- Cerebral Hemodynamics and Cognitive Function in Cirrhotic Patients with Hepatic Encephalopathy (Q37554174) (← links)
- Advances in the evaluation and management of minimal hepatic encephalopathy (Q37798193) (← links)
- Adjuvant Nutrition Management of Patients with Liver Failure, Including Transplant (Q37881468) (← links)
- Management of Overt Hepatic Encephalopathy (Q37982866) (← links)
- Perioperative nutritional therapy in liver transplantation (Q38182848) (← links)
- Management of covert hepatic encephalopathy (Q38515281) (← links)
- Sodium benzoate for treatment of hepatic encephalopathy (Q38633241) (← links)
- Hepatic encephalopathy: what the multidisciplinary team can do. (Q39230493) (← links)
- The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial. (Q39275984) (← links)
- Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis (Q39781817) (← links)
- Delivery of glutamine synthetase gene by baculovirus vectors: a proof of concept for the treatment of acute hyperammonemia. (Q42001080) (← links)
- Astroglial integrins in the development and regulation of neurovascular units (Q42427133) (← links)
- Induction of systemic oxidative stress leads to brain oedema in portacaval shunted rats. (Q43521848) (← links)
- Nutritional Therapy in Liver Transplantation (Q44281541) (← links)
- Lactulose mediates suppression of dextran sodium sulfate-induced colon inflammation by increasing hydrogen production. (Q46018290) (← links)
- Glutathione peroxidases as oncotargets (Q46267710) (← links)
- Hyperammonemia enhances the function and expression of P-glycoprotein and Mrp2 at the blood-brain barrier through NF-κB. (Q48557558) (← links)
- Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System (Q57825805) (← links)
- The healing effect of Curcuma longa on liver in experimental acute hepatic encephalopathy of rat (Q58227732) (← links)
- AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile duct-ligated rats (Q83559936) (← links)
- Sarcopenia: Ammonia metabolism and hepatic encephalopathy (Q90045152) (← links)
- Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis (Q90609973) (← links)